InZS AssociatesbySebastian Karl·Aug 11Biosimilar substitution in France: Tip of the iceberg for biosimilars policy in EuropeFrance’s biosimilar shift reveals how manufacturers can compete as pharmacy substitution expands across Europe.
InZS AssociatesbySebastian Karl·Jun 2Pharma engagement is broken: How customer engagement is fracturing and what you can do about itThe old pharma playbook is cracking. Growth now depends on smarter, leaner and more targeted GTM models.A response icon2A response icon2
